Quick Takeaways: Why It Matters? Elanco is extending its Advantage franchise into the collar segment with an over‑the‑counter, one‑size, water‑resistant dog collar that kills fleas and ticks and repels mosquitoes for four months, meaning most pets need only three collars per ye...
Quick Takeaways: Why It Matters? Parnell is bolstering its US footprint by buying Noble Pharma, adding an FDA and DEA‑accredited plant in Wisconsin with broad dosage-form capabilities to secure supply and support portfolio growth. The acquisition turns Noble’s CDMO-style ...
Quick Takeaways: Why It Matters? nixiFLOR gives vets and producers a lower‑cost, first‑generic alternative to Resflor Gold with the same florfenicol–flunixin combo and FDA‑confirmed bioequivalence for BRD treatment and BRD‑associated fever in beef and non‑l...
Shots: Why It Matters? Designating Wamego as its global HQ formalizes Axiota’s shift from a product-focused business to an integrated innovation hub, anchoring manufacturing, R&D, and scientific operations in the heart of the KC Animal Health Corridor n...
Quick Takeaways: Why It Matters? Piclidenoson’s Phase 2 enrollment milestone, fully funded by Vetbiolix, moves this A3 adenosine receptor agonist closer to potential registration as a chronic oral osteoarthritis option in dogs, with LOAD, VAS, and ...
Quick Takeaways: Why It Matters? By extending Bravecto Quantum’s label to cover Asian longhorned and Gulf Coast ticks for a full 12 months, Merck further differentiates the product as the longest‑lasting, broadest‑spectrum injectable parasiticide available exclusively...
Quick Takeaways: Why It Matters? Relocating the HQ to Boston embeds Dechra in a top-tier life sciences cluster, improving access to R&D talent, BD opportunities, and capital for innovation-driven growth. The shift also signals a stronger strategic emphasis on...
Quick Takeaways Why It Matters? Parnell strengthens its position in the controlled veterinary injectables segment, gaining preference among practices prioritizing safety-differentiated euthanasia agents. Visual dye innovation reduces medication errors, accelerating adopti...
Quick Takeaways: Why It Matters? The VievePharm deal gives Zenex a certified Western European manufacturing and sales base plus advanced bolus technology, accelerating its shift from an India‑focused player to a global naturals-led animal health company alig...
Quick Takeaways Why It Matters? Merck Animal Health strengthens its dermatology franchise with a differentiated, second-generation JAK inhibitor positioned as a convenient, first-line option for allergic pruritus. Once-daily dosing and rapid onset are likely to ...
